ATE170399T1 - Zusammensetzung und verfahren zur behandlung viraler infektionen - Google Patents

Zusammensetzung und verfahren zur behandlung viraler infektionen

Info

Publication number
ATE170399T1
ATE170399T1 AT90905295T AT90905295T ATE170399T1 AT E170399 T1 ATE170399 T1 AT E170399T1 AT 90905295 T AT90905295 T AT 90905295T AT 90905295 T AT90905295 T AT 90905295T AT E170399 T1 ATE170399 T1 AT E170399T1
Authority
AT
Austria
Prior art keywords
composition
viral infections
treating viral
agents
homologs
Prior art date
Application number
AT90905295T
Other languages
English (en)
Inventor
Daniel Meruelo
Gad Lavie
Yehuda Mazur
Original Assignee
Univ New York
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Yeda Res & Dev filed Critical Univ New York
Application granted granted Critical
Publication of ATE170399T1 publication Critical patent/ATE170399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90905295T 1989-03-16 1990-03-16 Zusammensetzung und verfahren zur behandlung viraler infektionen ATE170399T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32417789A 1989-03-16 1989-03-16
US41716389A 1989-10-04 1989-10-04
US48851890A 1990-02-27 1990-02-27

Publications (1)

Publication Number Publication Date
ATE170399T1 true ATE170399T1 (de) 1998-09-15

Family

ID=27406317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905295T ATE170399T1 (de) 1989-03-16 1990-03-16 Zusammensetzung und verfahren zur behandlung viraler infektionen

Country Status (11)

Country Link
US (1) US6150414A (de)
EP (1) EP0426785B1 (de)
JP (1) JPH04504849A (de)
AT (1) ATE170399T1 (de)
AU (1) AU640131B2 (de)
CA (1) CA2029863C (de)
DE (1) DE69032613T2 (de)
DK (1) DK0426785T3 (de)
ES (1) ES2123499T3 (de)
IL (1) IL93682A (de)
WO (1) WO1990010438A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06504791A (ja) * 1991-04-10 1994-06-02 オクタマー，インコーポレイティド レトロウィルス複製の阻害のための方法
US6576784B1 (en) * 1993-05-27 2003-06-10 Yeda Research And Development Co. Ltd. Antiviral agents
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
ATE384795T1 (de) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic Modifizierte hiv env polypeptide
EP1141314A2 (de) 1998-12-31 2001-10-10 Chiron Corporation Für antigene polypeptide des hiv type c kodierende polynukleotide, entsprechende polypeptide und verwendungen davon
DE60125048T2 (de) * 2000-01-31 2007-07-12 New York University Polycyclische dianthrachinone als antikrebsmittel und antiangiogenesemittel
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2458995C (en) 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
JP4076749B2 (ja) * 2001-10-15 2008-04-16 富士フイルム株式会社 導電性有機化合物及び電子素子
WO2016145279A2 (en) * 2015-03-12 2016-09-15 Stc.Unm Compositions and methods that inhibit quorum sensing
EP4414354A3 (de) * 2016-03-01 2024-10-30 Soligenix, Inc. Systeme und verfahren zur herstellung von synthetischem hypericin
MX2020003695A (es) 2017-11-30 2020-08-03 Arrakis Therapeutics Inc Fotosondas de union a acido nucleico y usos de las mismas.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707704A (en) * 1951-09-29 1955-05-03 Schenley Ind Inc Process for the preparation of hypericin
US3974186A (en) * 1970-05-14 1976-08-10 Richardson-Merrell Inc. Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4670265A (en) * 1983-07-22 1987-06-02 Sydiskis Robert J Aloe emodin and other anthraquinones and anthraquinone-like compounds from plants virucidal against herpes simplex viruses
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
IL79661A (en) * 1986-08-08 1991-01-31 Yeda Res & Dev Antiviral composition containing hypericin or pseudohypericin
WO1989001329A1 (en) * 1987-08-10 1989-02-23 New York University Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections
US4898891A (en) * 1987-08-07 1990-02-06 Yeda Research And Development Company Ltd. Antiviral compositions
AU3294289A (en) * 1988-03-23 1989-10-16 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
JPH0244231A (ja) * 1988-08-04 1990-02-14 Fuji Electric Co Ltd 中和滴定装置

Also Published As

Publication number Publication date
WO1990010438A1 (en) 1990-09-20
EP0426785A4 (en) 1991-11-13
US6150414A (en) 2000-11-21
DE69032613T2 (de) 1999-02-25
EP0426785B1 (de) 1998-09-02
AU5338790A (en) 1990-10-09
IL93682A (en) 1996-06-18
DE69032613D1 (de) 1998-10-08
DK0426785T3 (da) 1999-05-31
JPH04504849A (ja) 1992-08-27
AU640131B2 (en) 1993-08-19
EP0426785A1 (de) 1991-05-15
CA2029863C (en) 2001-10-30
CA2029863A1 (en) 1990-09-17
ES2123499T3 (es) 1999-01-16

Similar Documents

Publication Publication Date Title
DE69032613D1 (de) Zusammensetzung und verfahren zur behandlung viraler infektionen
BR9913157A (pt) Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
EA199901031A1 (ru) Производные бензимидазола
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ES2165269A1 (es) Derivados de alfa-cetoamidas.
BR9711095A (pt) Composto de ciclopentano substituìdo, composição e método para inibir neuraminidase de vìrus influenza e método para tratar infecção de vìrus influenza
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
ES2174921T3 (es) Inhibidores de la proteasa del vih.
ES8502097A1 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ATE213231T1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
DE3881864D1 (de) Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
ATE247672T1 (de) Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen
MX9300008A (es) Nucleosidos terapeuticos.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
EA200001028A1 (ru) Производные 2"-деоксигигромицина
BR9205877A (pt) Processo e composiçao para o tratamento de infecçoes por herpes.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee